Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation.

In further pursuing our search for potent and selective aromatase inhibitors, a new series of molecules was designed and synthesized, exploring possible structural modifications of a previously identified xanthone scaffold. Among them, highly potent compounds, with inhibitory activity in the low nanomolar range, were found. In particular, substitution of the heterocyclic oxygen atom in the xanthone core by a sulfur atom and/or increase in structure flexibility seemed to be favorable for the interaction with the enzyme.

[1]  R. Hartmann,et al.  Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[2]  Ellis Mj,et al.  First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen? , 2004 .

[3]  A. Cavalli,et al.  A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase. , 2001, Journal of medicinal chemistry.

[4]  C. Pouget,et al.  New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation. , 2008, Bioorganic & medicinal chemistry.

[5]  R. Bergan,et al.  Phase II study of mitoxantrone and ketoconazole for hormone‐refractory prostate cancer , 2006, Cancer.

[6]  A. Cavalli,et al.  From nonsteroidal aromatase inhibitors to multifunctional drug candidates: classic and innovative strategies for the treatment of breast cancer. , 2008, Current topics in medicinal chemistry.

[7]  W. Denny,et al.  Potential antitumor agents. 62. Structure-activity relationships for tricyclic compounds related to the colon tumor active drug 9-oxo-9H-xanthene-4-acetic acid. , 1991, Journal of medicinal chemistry.

[8]  Thompson Ea,et al.  Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. , 1974 .

[9]  V. Njar,et al.  Comprehensive Pharmacology and Clinical Efficacy of Aromatase Inhibitors , 1999, Drugs.

[10]  W. Denny,et al.  Potential antitumor agents. 60. Relationships between structure and in vivo colon 38 activity for 5-substituted 9-oxoxanthene-4-acetic acids. , 1990, Journal of medicinal chemistry.

[11]  M. E. Sousa,et al.  Xanthone derivatives: new insights in biological activities. , 2005, Current medicinal chemistry.

[12]  B. Potter,et al.  Non‐Steroidal Aromatase Inhibitors Based on a Biphenyl Scaffold: Synthesis, in vitro SAR, and Molecular Modelling , 2008, ChemMedChem.

[13]  Takashi Suzuki,et al.  In situ estrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology , 2009, Pathology international.

[14]  Marcy J. Balunas,et al.  Isolation and Characterization of Aromatase Inhibitors from Brassaiopsis glomerulata (Araliaceae). , 2009, Phytochemistry letters.

[15]  Marcy J. Balunas,et al.  Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. , 2008, Journal of natural products.

[16]  B. Potter,et al.  Synthesis of Aromatase Inhibitors and Dual Aromatase Steroid Sulfatase Inhibitors by Linking an Arylsulfamate Motif to 4‐(4H‐1,2,4‐triazol‐4‐ylamino)benzonitrile: SAR, Crystal Structures, in vitro and in vivo Activities , 2008, ChemMedChem.

[17]  Y. Na.  Recent cancer drug development with xanthone structures , 2009 .

[18]  B. Potter,et al.  Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template. , 2010, Journal of medicinal chemistry.

[19]  R. Santen,et al.  History of aromatase: saga of an important biological mediator and therapeutic target. , 2009, Endocrine reviews.

[20]  A. Cavalli,et al.  Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme. , 2006, Journal of medicinal chemistry.

[21]  Silvia Gobbi,et al.  Imidazolylmethylbenzophenones as highly potent aromatase inhibitors. , 2007, Journal of medicinal chemistry.

[22]  R. Hartmann,et al.  Synthesis of Hydroxy Derivatives of Highly Potent Non-steroidal CYP 17 Inhibitors as Potential Metabolites and Evaluation of their Activity by a Non Cellular Assay using Recombinant Human Enzyme , 2004, Journal of enzyme inhibition and medicinal chemistry.

[23]  W. Denny,et al.  Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo. , 1989, Journal of medicinal chemistry.

[24]  J. Tobias,et al.  Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer , 2008, Drugs.